Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy

Cancer Research

Volumn 56, Issue 17, 1996, Pages 3870-3874

  Midis, Gregory P ^a,b   Shen, Yu ^a   Owen Schaub, Laurie B ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; PRIORITY JOURNAL; SERUM; SOLID TUMOR;

ANTIGENS, CD95; ANTIGENS, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEOPLASMS; SOLUBILITY;

EID: 0029838411     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Nagata, S. Fas and Fas ligand: a death factor and its receptor Adv. Immunol., 57: 129-144, 1994.
2. Owen-Schaub, L B., Yonehara, S., Crump, W. L., and Grimm, E. A DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement Cell. Immunol , 140: 197-205, 1992.
3. Owen-Schaub, L. B., Radinsky, R , Kruzel, E., Berry, K., and Yonehara, S. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res , 54: 1580-1586, 1994.
4. Leithauser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Brüderlein, S., Henne, C , Schmidt, A., Debatin, K-M., Krammer, P H., and Möller, P. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest , 69: 415-429, 1993
5. Cheng, J., Zhou, T , Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P J., and Mountz, J. D Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule Science (Washington DC), 263: 1759-1762, 1994
6. Owen-Schaub, L. B., Angelo, L S , Radinsky, R., Ware, C. F., Gesner, T G., and Bartos, D. P Soluble Fas/APO-1 in tumor cells, a potential regulator of apoptosis? Cancer Lett., 94: 1-8, 1995.
7. Cascino, I., Fiucci, G., Papoff, G., and Ruberti, G. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol., 154: 2706-2713, 1995.
8. Natoli, G , Ianni, A., Costanzo, A., De Petrillo, G., Ilari, I., Chirillo, P , Balsano, C., and Levrero, M. Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene, 10, 1157-1164, 1995.
9. Liu, C , Cheng, J , and Mountz, J. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem. J., 310: 957-963, 1995.
10. Weller, M., Malipiero, U , Rensing-Ehl, A., Barr, P. J , and Fontana, A. Fas/APO-1 gene transfer for human malignant glioma. Cancer Res., 55: 2936-2944, 1995.
11. Knipping, E., Debatin, K-M , Stricker, K , Heilig, B., Eder, A., and Krammmer, P. H. Identification of soluble APO-I in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood, 85: 1562-1569, 1995.
12. Sato, T., Irie, S., Kitada, S., and Reed, J. C. FAP-1, a protein tyrosine phosphatase that associates with Fas Science (Washington DC), 268: 411-415, 1995.
13. L. Immunology, 3: 87-98, 1995.
14. Zornig, M , Grzeschiczek, A , Kowalski, M-B., Hartmann, K-U , and Moröy, T Loss of Fas/APO-I receptor accelerates lymphomagenesis in Eμ L-MYC transgenic mice but not in animals infected with MoMuLV Oncogene, 10: 2397-2401, 1995.
15. Crowe, P. D., Van Arsdale, T. L., Walter, B. N , Dahms, K. M., and Ware, C F. Production of lymphotoxin (LT α) and a soluble dimeric form of its receptor using the baculovirus expression system. J. Immunol. Methods, 163: 79-89, 1994.
16. Gruss, H-J., and Dower, S. K Tumor necrosis factor ligand superfamily involvement in the pathology of malignant lymphomas. Blood, 55: 3378-3404, 1995.
17. Smith, C. A , Farrah, T., and Goodwill, R. G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell, 76: 959-962, 1994.
18. Thompson, C B Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995
19. Symonds, H , Krail, L., Remington, L , Saenz-Robles, M., Lowe, S., Jacks, T., and Van Dyke, T p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78 703-711, 1994.
20. Möller, P., Koretz, K., Leithhäuser, F., Brüderlein, S., Henne, C , Quentmeir, A., and Krammer, P. H. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer, 57: 371-377, 1994